75%Confidence
0Views
FDASource
2026-04-11Date
Summary
Annora Pharma's Class III recall for Pitavastatin due to incorrect tablet mixing poses a low health risk but reveals serious packaging errors in a cholesterol drug. This could lead to supply chain audits and affect Northstar Rx's reliability as a generic supplier.
Actionable: Audit Northstar Rx's quality control systems and consider secondary suppliers for Pitavastatin to mitigate risks.
AI Confidence: 75%
Data Points
firmAnnora Pharma Private Limited
classificationClass III
statusOngoing
distributionTN
productPitavastatin Tablets, 2 mg, packaged in 90-count bottles, Rx only, Manufactured for: Northstar Rx LLC, Memphis, TN 38141, Manufactured by: Annora Phar
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now